Levothyroxine Sodium (Par Pharmaceutical Inc.)


Welcome to the PulseAid listing for the Levothyroxine Sodium drug offered from Par Pharmaceutical Inc.. This l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Par Pharmaceutical Inc.
NON-PROPRIETARY NAME: LEVOTHYROXINE SODIUM ANHYDROUS
SUBSTANCE NAME: LEVOTHYROXINE SODIUM ANHYDROUS
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: l-Thyroxine [EPC],Thyroxine [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-06-24
END MARKETING DATE: 0000-00-00


Levothyroxine Sodium HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLevothyroxine Sodium from Par Pharmaceutical Inc.
LABELER NAME: Par Pharmaceutical Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 100(ug/5mL)
START MARKETING DATE: 2011-06-24
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42023-201_9d815416-11c9-470e-a82f-89b0bf232e12
PRODUCT NDC: 42023-201
APPLICATION NUMBER: NDA202231

Other LEVOTHYROXINE SODIUM ANHYDROUS Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions, Inc.Levothyroxine Sodium
Fresenius Kabi USA, LLCLevothyroxine Sodium
Par Pharmaceutical Companies, Inc.Levothyroxine Sodium
Par Pharmaceutical Inc.Levothyroxine Sodium
Unit Dose ServicesLevothyroxine Sodium